Showing results 8 to 24 of 24
< previous
| Issue Date | Title | Author(s) |
| 2012-01 | Microparticle Conferred MicroRNA Profiles - Implications In The Transfer And Dominance Of Cancer Traits | Jaiswal, R; Luk, F; Gong, J; Mathys, J; Grau, G; Bebawy, M |
| 2012-06-08 | Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits | Jaiswal, R; Luk, F; Gong, J; Mathys, JM; Grau, GER; Bebawy, M |
| 2012-01 | Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. | Jaiswal, R; Luk, F; Gong, J; Mathys, J-M; Grau, GER; Bebawy, M |
| 2013-01 | Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance | Gong, J; Luk, F; Jaiswal, R; George, AM; Grau, G; Bebawy, M |
| 2013-12-05 | Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance | Gong, J; Luk, F; Jaiswal, R; George, AM; Grau, GER; Bebawy, M |
| 2015-08-01 | Microparticles as novel prognostic markers in multiple myeloma | Rajeev Krishnan, S; Bebawy, M; Brown, RD; Luk, F; Kwan, Y |
| 2015-02-15 | Microparticles derived from drug-resistant cells regulate miR-503 and PYK2 to promote migration and invasion in breast cancer | Gong, J; Luk, F; Jaiswal, R; Bebawy, M |
| 2015-04 | Microparticles in cancer: A review of recent developments and the potential for clinical application | Gong, J; Jaiswal, R; Dalla, P; Luk, F; Bebawy, M |
| 2015-04-01 | Microparticles in cancer: A review of recent developments and the potential for clinical application | Gong, J; Jaiswal, R; Dalla, P; Luk, F; Bebawy, M |
| 2013-09-02 | Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways | Lu, JF; Luk, F; Gong, J; Jaiswal, R; Grau, GER; Bebawy, M |
| 2014-01-01 | Microparticles mediate the intercellular regulation of microRNA-503 and proline-rich tyrosine kinase 2 to alter the migration and invasion capacity of breast cancer cells | Gong, J; Luk, F; Jaiswal, R; Bebawy, M |
| 2016-07-01 | Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review) | Krishnan, SR; Jaiswal, R; Brown, RD; Luk, F; Bebawy, M |
| 2015-09-01 | Multiple myeloma: A novel tailor-made therapeutic management. | Krishnan, SR; Bebawy, M; Luk, F; Brown, RD; Kwan, YL |
| 2015-02-15 | A novel personalized therapeutic management in multiple myeloma | Krishnan, RS; Luk, F; Brown, RD; Kwan, YL; Bebawy, M |
| 2014-01-01 | Proteome analysis of multidrug-resistant, breast cancer-derived microparticles | Pokharel, D; Padula, MP; Lu, JF; Tacchi, JL; Luk, F; Djordjevic, SP; Bebawy, M |
| 2014-08 | SYNTHESIS OF CURCUMIN NANOPARTICLES FOR LUNG CANCER THERAPY | Lee, W-H; Ong, H-X; Loo, C-Y; Traini, D; Young, PM; Luk, F; Bebawy, M; Rohanizadeh, R |
| 2015-05-01 | Targeting microparticle biogenesis: A novel approach to the circumvention of cancer multidrug resistance | Roseblade, A; Luk, F; Ung, A; Bebawy, M |
